Expression of concern
Induction of ErbB-3 Expression by α6β4 Integrin Contributes to Tamoxifen Resistance in ERβ1-Negative Breast Carcinomas
Paper Information
Record ID:
36297
Author(s):
Publication Date:
February 13, 2008
Retraction Date:
March 25, 2022
(3.7 years years ago)
Subjects:
Institutions:
Country:
🇮🇹 ItalyArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1371/journal.pone.0266300Citations (53)
53
Total Citations2
Post-Retraction(3.8%)
49
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
1
After 2+ years
913
Days since retraction (latest)
Experimental Endocrine Resistance: Concepts and Strategies
Robert I. Nicholson, Iain R. Hutcheson, Stephen Hiscox et al. (5 authors)
Springer eBooks
Published: Jan 2009
4823 days before retraction
Integrin and Growth Factor Receptor Alliance in Angiogenesis
Payaningal R. Somanath, Alieta Ciocea, Tatiana V. Byzova
Cell Biochemistry and Biophysics
Open Access
Published: Dec 2008
119 citations
119 citations
4862 days before retraction
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study
Flavia Novelli, Michele Stanislaw Milella, Elisa Melucci et al. (13 authors)
Breast Cancer Research
Open Access
Published: Sep 2008
108 citations
108 citations
4950 days before retraction
Quick Stats
Total Citations:
53
Years Since Retraction:
3.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025